LEAF
Kelsey Moody (CEO of Ichor Therapeutics) discusses the development of a gut stable antibody mimic for Parkinson’s Disease and announces ten million dollars of investment by Juvenescence in Ichor portfolio company Antoxerene, Inc., at the Ending Age Related Diseases Conference in NYC.
More at: https://www.leafscience.org/ending-age-related-diseases-2018/
Source:
